Compile Data Set for Download or QSAR
Report error Found 31 Enz. Inhib. hit(s) with all data for entry = 1503
TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327788(US9663475, Compound A7)
Affinity DataIC50: 140nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327800(US9663475, Compound A16)
Affinity DataIC50: 170nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327812(US9663475, Compound A22)
Affinity DataIC50: 180nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327811(US9663475, Compound A21)
Affinity DataIC50: 220nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327823(US9663475, Compound A30)
Affinity DataIC50: 240nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327802(US9663475, Compound A17)
Affinity DataIC50: 270nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327803(US9663475, Compound A18)
Affinity DataIC50: 270nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327792(US9663475, Compound A10)
Affinity DataIC50: 300nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327822(US9663475, Compound A29)
Affinity DataIC50: 310nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327807(US9663475, Compound A19)
Affinity DataIC50: 320nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327789(US9663475, Compound A9 | US9663475, Compound A8)
Affinity DataIC50: 510nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327798(US9663475, Compound A14)
Affinity DataIC50: 620nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327793(US9663475, Compound A11)
Affinity DataIC50: 780nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327794(US9663475, Compound A12)
Affinity DataIC50: 810nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327784(US9663475, Compound A3)
Affinity DataIC50: 960nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327789(US9663475, Compound A9 | US9663475, Compound A8)
Affinity DataIC50: 1.10E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327799(US9663475, Compound A15)
Affinity DataIC50: 1.20E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327787(US9663475, Compound A6)
Affinity DataIC50: 1.40E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327786(US9663475, Compound A5)
Affinity DataIC50: 2.20E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327779(US9663475, Compound A1 | US9663475, Compound A2)
Affinity DataIC50: 2.30E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327796(US9663475, Compound A13)
Affinity DataIC50: 2.50E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327816(US9663475, Compound A25)
Affinity DataIC50: 2.50E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327825(US9663475, Compound A31)
Affinity DataIC50: 2.50E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327779(US9663475, Compound A1 | US9663475, Compound A2)
Affinity DataIC50: 2.70E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327813(US9663475, Compound A24 | US9663475, Compound A23)
Affinity DataIC50: 2.90E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327817(US9663475, Compound A26)
Affinity DataIC50: 3.00E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327819(US9663475, Compound A27)
Affinity DataIC50: 3.30E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327809(US9663475, Compound A20)
Affinity DataIC50: 3.80E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327813(US9663475, Compound A24 | US9663475, Compound A23)
Affinity DataIC50: 4.20E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327785(US9663475, Compound A4)
Affinity DataIC50: 8.40E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM327821(US9663475, Compound A28)
Affinity DataIC50: 2.40E+4nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent